Ignite Creation Date:
2025-12-24 @ 3:31 PM
Ignite Modification Date:
2026-01-06 @ 2:02 PM
Study NCT ID:
NCT04067492
Status:
TERMINATED
Last Update Posted:
2022-07-25
First Post:
2019-08-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Evaluation of RPH-104 Administered at Different Doses to Patients With Acute Gout Attack
Sponsor:
R-Pharm
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CL04018054
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None